Short Interest in Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Increases By 625.5%

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) saw a large increase in short interest in February. As of February 15th, there was short interest totalling 37,000 shares, an increase of 625.5% from the January 31st total of 5,100 shares. Based on an average trading volume of 82,800 shares, the short-interest ratio is currently 0.4 days.

Algernon Pharmaceuticals Price Performance

Algernon Pharmaceuticals stock remained flat at $0.06 during midday trading on Thursday. Algernon Pharmaceuticals has a 1 year low of $0.04 and a 1 year high of $0.12. The company’s fifty day moving average is $0.06 and its two-hundred day moving average is $0.06.

Algernon Pharmaceuticals Company Profile

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia.